Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI (PACE-4-TAVI)
Atrioventricular Block, Second and Third Degree
About this trial
This is an interventional prevention trial for Atrioventricular Block, Second and Third Degree focused on measuring Pacemaker, Transcatheter Aortic Valve Replacement, Conduction System Pacing (CSP), Atrioventricular Block, Congestive Heart Failure, Bradycardia
Eligibility Criteria
Inclusion Criteria: transcatheter aortic valve implantation (TAVI) in up to 30 days before qualification to pacemaker implantation Fulfilled criteria for permanent pacemaker implantation according do 2021 ESC guidelines Written informed consent Age of at least 18 years Exclusion Criteria: Permanent pacemaker implantation before TAVI procedure The occurrence of conduction disturbances more than 30 days after TAVI procedure No written informed consent Inability to obtain informed consent from participant Predicted inability to obtain cooperation from patient during observation period
Sites / Locations
- Medical University of Silesia in Katowice
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Conduction System Pacing
Standard Pacing Method
Patients who receive Conduction System Pacing in form of Left Bundle Branch Area Pacing or His Bundle Pacing.
Patients who receive currently standard pacing method with exact type of ventricular pacing depending upon left ventricular ejection fraction (LVEF): right ventricular pacing in case of LVEF >= 40% or biventricular pacing if LVEF is determined to be less than 40%, as per current ESC guidelines.